Aug 2 (Reuters) - British engineering firm Smiths Group said on Monday it will sell its medical unit for $2.3 billion including debt to a subsidiary of funds advised by U.S. private equity firm TA Associates, and planned to make shareholder returns following the sale. (Reporting by Yadarisa Shabong in Bengaluru; Editing by Shinjini Ganguli)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,627 GBX | -0.49% | +3.04% | -7.68% |
Apr. 15 | Envista Holdings Names Paul Keel as CEO | MT |
Apr. 11 | Dwindling US Fed cut hope unnerves markets | AN |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.68% | 7.02B | |
+13.37% | 883B | |
0.00% | 239B | |
+27.44% | 178B | |
-6.46% | 128B | |
+34.81% | 79.12B | |
-4.32% | 74.88B | |
-14.95% | 51.46B | |
-23.72% | 38.61B | |
+24.46% | 32.72B |
- Stock Market
- Equities
- SMIN Stock
- News Smiths Group plc
- Smiths : to sell medical division for $2.3 bln including debt